Clinical Trial

The IPAD Cohort Study: Insomnia and Positive Airway Pressure Adherence in Children and Adolescents

Study acronym: IPAD
Recruiting
View on ClinicalTrials.gov →
Summary
Positive Airway Pressure (PAP) is a treatment used to help people with sleep-disordered breathing, particularly those with obstructive sleep apnea (OSA). The device delivers pressurized air through a mask to keep the airways open during sleep, improving breathing and preventing interruptions in sleep. Studying how insomnia affects PAP adherence in children can help improve future treatments. However, no long-term studies have looked at this in children. Based on previous research, the investigators plan to conduct a study across multiple centers focusing on children with OSA starting PAP therapy. The study will explore how insomnia affects PAP adherence and how race and ethnicity play a role.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-09.
Trial Details
NCT Number NCT07176767
Lead Sponsor Lena Xiao
Collaborators: American Academy of Sleep Medicine, The Hospital for Sick Children
Conditions Sleep Apnea, Obstructive, Insomnia
Enrollment 82 participants
Start Date 2025-06-12
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-23